zirconium has been researched along with Carcinoma, Pancreatic Ductal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
An, S; Huang, G; Huang, W; Liang, C; Liu, J; Wang, C; Wei, W; Wu, Q; Zhang, D; Zhang, Y; Zhao, H | 1 |
Barnhart, TE; Cai, W; Cao, T; Chen, W; Engle, JW; Fan, K; Jiang, D; Li, M; Liu, J; Wei, W | 1 |
Caen, JD; Dacek, MM; Dilling, TR; Evans, MJ; Fox, IL; Henry, KE; Lewis, JS | 1 |
3 other study(ies) available for zirconium and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
ImmunoPET Imaging of CD47 with VHH-Derived Tracers in Pancreatic Cancers.
Topics: Animals; Carcinoma, Pancreatic Ductal; CD47 Antigen; Cell Line, Tumor; Gallium Radioisotopes; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Tissue Distribution; Zirconium | 2023 |
ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Intercellular Adhesion Molecule-1; Mice; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Tissue Distribution; Zirconium | 2021 |
A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Mitogen-Activated Protein Kinase 3; Molecular Targeted Therapy; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Radioisotopes; Signal Transduction; Transferrin; Zirconium | 2019 |